|
Post by beebs on Nov 30, 2012 16:23:27 GMT -5
Previous posts warn of psychotropics associated with higher rates of cardiovascular events below the age of 40 years old. Associated side effects with psychotropics: parkinsonian type of symptoms, dystonia, incontinence, palpitations, erectile dysfunction, anxiety, diabetes, metabolic dysfunction, depression, insomnia, psychosis, hallucinations, allergies, confusion, incoherence, MS type of symptoms, shaking, sweating profusely, alteration in cognition, behavior, mood fluctuations, change in personality and behavior, and more. If you suffer from any of the above, look up medications side effects you are taking or taken during the previous two to four years, local and general anesthesia, thyroid function or full hormones profile, infections, and other biological illnesses that are known to cause CNS like symptoms, BEFORE taking psychotropics!! The article below discusses psychotropics and cardiac event in adults age over 40. Excerpt: "Minimizing Bias Most antipsychotic prescriptions in people older than 40 years involve off-label use of AAPs, the authors write. There has been "growing concern" about cardiovascular and metabolic morbidity with certain AAPs. The US Food and Drug Administration issued a warning regarding cerebrovascular adverse events and a boxed warning regarding increased mortality with AAP use for dementia-related psychosis. Because the patients in the current study were all diagnosed with conditions with psychotic symptoms that required antipsychotic drug treatment according to their treating physicians, no placebo was used in the trial." Article: www.medscape.com/viewarticle/775125?src=nldne
|
|
|
Post by beebs on Dec 17, 2012 15:46:43 GMT -5
Lack of scientific evidence in regards to chemical imbalances, Big Pharma's manipulation of theories to market ineffective drugs, other than causing chemical imbalances, addiction, and CNS symptoms, indigestion, neuropathy, erectile dysfunction, incontinence, poor cognition, altering mood, personality, and behavior, and over serious side effects, such as cardiac, pulmonary, liver and kidney damage, as well as mitochondrial, immune system and so forth, should be scrutinized. Before embarking on Z-benzos & other psychotropics, analgesics, read up. Below is an excerpt concerning the above. READ IT, and save yourself years of torture and misery. Easy read. Excerpt: " Contemporary neuroscience research has failed to confirm any serotonergic lesion in any mental disorder, and has in fact provided significant counterevidence to the explanation of a simple neurotransmitter deficiency. Modern neuroscience has instead shown that the brain is vastly complex and poorly understood [11]. While neuroscience is a rapidly advancing field, to propose that researchers can objectively identify a “chemical imbalance” at the molecular level is not compatible with the extant science. In fact, there is no scientifically established ideal “chemical balance” of serotonin, let alone an identifiable pathological imbalance. To equate the impressive recent achievements of neuroscience with support for the serotonin hypothesis is a mistake." Whole article: www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0020392
|
|
|
Post by beebs on Dec 18, 2012 18:09:54 GMT -5
Article mentions top ten drugs linked to aggressive behavior, homicidal outbursts. Full article: healthland.time.com/2011/01/07/top-ten-legal-drugs-linked-to-violence/10. Desvenlafaxine (Pristiq) An antidepressant which affects both serotonin and noradrenaline, this drug is 7.9 times more likely to be associated with violence than other drugs. 9. Venlafaxine (Effexor) A drug related to Pristiq in the same class of antidepressants, both are also used to treat anxiety disorders. Effexor is 8.3 times more likely than other drugs to be related to violent behavior. (More on Time.com: Adderall May Not Make You Smarter, But It Makes You Think You Are) 8. Fluvoxamine (Luvox) An antidepressant that affects serotonin (SSRI), Luvox is 8.4 times more likely than other medications to be linked with violence 7. Triazolam (Halcion) A benzodiazepine which can be addictive, used to treat insomnia. Halcion is 8.7 times more likely to be linked with violence than other drugs, according to the study. 6) Atomoxetine (Strattera) Used to treat attention-deficit hyperactivity disorder (ADHD), Strattera affects the neurotransmitter noradrenaline and is 9 times more likely to be linked with violence compared to the average medication. 5) Mefoquine (Lariam) A treatment for malaria, Lariam has long been linked with reports of bizarre behavior. It is 9.5 times more likely to be linked with violence than other drugs. 4) Amphetamines: (Various) Amphetamines are used to treat ADHD and affect the brain’s dopamine and noradrenaline systems. They are 9.6 times more likely to be linked to violence, compared to other drugs. 3) Paroxetine (Paxil) An SSRI antidepressant, Paxil is also linked with more severe withdrawal symptoms and a greater risk of birth defects compared to other medications in that class. It is 10.3 times more likely to be linked with violence compared to other drugs. (More on Time.com: Healthland’s Guide to Life 2011) 2) Fluoxetine (Prozac) The first well-known SSRI antidepressant, Prozac is 10.9 times more likely to be linked with violence in comparison with other medications. 1) Varenicline (Chantix) The anti-smoking medication Chantix affects the nicotinic acetylcholine receptor, which helps reduce craving for smoking. Unfortunately, it’s 18 times more likely to be linked with violence compared to other drugs — by comparison, that number for Xyban is 3.9 and just 1.9 for nicotine replacement. Because Chantix is slightly superior in terms of quit rates in comparison to other drugs, it shouldn’t necessarily be ruled out as an option for those trying to quit, however. Related Links: Read more: healthland.time.com/2011/01/07/top-ten-legal-drugs-linked-to-violence/#ixzz2FRpBoRwA
|
|
|
Post by beebs on Dec 19, 2012 16:07:14 GMT -5
Topical, see the first link: www.dovepress.com/articles.php?article_id=7993 Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 familywww.dovepress.com/articles.php?article_id=7993Yolande Lucire, Christopher Crotty Edgecliff Centre, Edgecliff, NSW, Australia Purpose: To examine the relation between variant alleles in 3 CYP450 genes (CYP2D6, CYP2C9 and CYP2C19), interacting drugs and akathisia in subjects referred to a forensic psychiatry practice in Sydney, Australia. Patients and methods: This paper concerns 10/129 subjects who had been referred to the first author’s practice for expert opinion or treatment. More than 120 subjects were diagnosed with akathisia/serotonin toxicity after taking psychiatric medication that had been prescribed for psychosocial distress. They were tested for variant alleles in CYP450 genes, which play a major role in Phase I metabolism of all antidepressant and many other medications. Eight had committed homicide and many more became extremely violent while on antidepressants. Ten representative case histories involving serious violence are presented in detail. Results: Variant CYP450 allele frequencies were higher in akathisia subjects compared with random primary care patients tested at the same facility. Ten subjects described in detail had variant alleles for one or more of their tested CYP450 genes. All but two were also on interacting drugs, herbals or illicit substances, impairing metabolism further. All those described were able to stop taking antidepressants and return to their previously normal personalities. Conclusion: The personal, medical, and legal problems arising from overuse of antidepressant medications and resulting toxicity raise the question: how can such toxicity events be understood and prevented? The authors suggest that the key lies in understanding the interplay between the subject’s CYP450 genotype, substrate drugs and doses, co-prescribed inhibitors and inducers and the age of the subject. The results presented here concerning a sample of persons given antidepressants for psychosocial distress demonstrate the extent to which the psychopharmacology industry has expanded its influence beyond its ability to cure. The roles of both regulatory agencies and drug safety “pharmacovigilantes” in ensuring quality and transparency of industry information is highlighted. Keywords: adverse drug reaction, drug therapy, safety pharmacogenetics, CYP1A2, CYP3A4 CYP2D6, CYP2C9, CYP2C19, drug metabolism, public health, suicide, violence, human rights
|
|
|
Post by beebs on Dec 29, 2012 9:37:45 GMT -5
An article published in Medscape discusses hospital admissions rose by 500% between 2001-2010, reported by the The Treatment Episode Data Set (TEDS), connected to Benzos and pain killers patients. Mentioned is substance abuse, which in this case, is clearly not. These drugs cause severe cognition dysfunction and confusion. High stats of 46% said to have comorbid psychiatric illness, which I believe are symptoms and side effects from those drugs. Todate, there are no treatment plan for withdrawal, other than prescribing more psychotropics. One positive from the report, is acknowledgment of side effects. www.samhsa.gov/data/2k12/TEDS-064/TEDS-Short-Report-064-Benzodiazepines-2012.htmTwo vids concerning psychiatry and drugs. Irrelevant who the messenger is, what matters, are the cold, brutal, hard facts. www.cchr.org/www.cchr.org/videos/psychiatry-an-industry-of-death-1.html
|
|